Pharma developments in 2022: what you need to know
A look at healthcare trends that will likely impact pharma's efforts to research and develop therapeutics in 2022
By
Technology
Latest in
Technology
Mapping the RNA therapeutics R&D landscape in 2022
Fueled by the successful utilisation of the mRNA Covid-19 vaccines, RNA therapeutics are expected to make larger strides in 2022
By
Magazine: Challenges in multiple drugs safety reporting
In this issue: Challenges in pharmacovigilance for treatments involving multiple drugs, the potential of 3D printing in drug manufacturing, opportunities…
By
How technology could transform drug research in 2022
Pharmaceutical Technology takes a look at some of the tech innovations set to impact drug discovery and development in 2022.
By
Lilly and Foghorn enter partnership to develop new cancer medicines
For the discovery programmes, Lilly will pay up to $1.3bn in payments to Foghorn on meeting development and marketing milestones.
Thermo Fisher acquires clinical research services provider PPD for $17.4bn
With the acquisition, PPD will be part of Thermo Fisher’s Laboratory Products and Services unit.
Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
Kaléo currently markets the AUVI-Q 0.15mg and 0.3mg, as well as the AUVI-q 0.1mg injections.
GreenLight and Samsung Biologics to produce Covid-19 vaccines
Samsung will use GreenLight’s manufacturing process to produce the vaccines.